Pharmafile Logo

OTC Awards

- PMLiVE

MHRA authorises Biogen’s higher-dose Spinraza for SMA treatment

SMA is a rare genetic neuromuscular condition affecting around 1,600 people in the UK

- PMLiVE

Beyond the injection: why the real work of weight loss starts where the drug leaves off

Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward

- PMLiVE

J&J’s Icotyde approved by US FDA for plaque psoriasis

Plaque psoriasis affects over 125 million people worldwide

- PMLiVE

Envision appoints Darren Coleman as Executive VP, Chief Information Officer

Coleman previously held senior leadership positions at Syneos Health and AI One

- PMLiVE

AL-S Pharma release new data from AP-101 phase 2 trial for ALS

ALS is a progressive neurodegenerative disease that affects the motor neurons of the brain and spinal cord

- PMLiVE

Envision appoints Jay Ferro as President, Technology and Chief Product Officer

Ferro was previously EVP, Chief Information, Technology & Product Officer at Clario

- PMLiVE

Grifols share results identifying early signs of Parkinson’s disease

Parkinson’s disease affects over six million people globally

- PMLiVE

Richmond Pharmacology appoints John Hotti as Chief Technology Officer

Hotti was previously Head of AI and CIO at Telrock Systems

- PMLiVE

Beyond the Linear Path: Leading with Your Full Self

Listen to the full episode here. In the latest episode of the Hear From Her podcast, Giulia Ghibellini (Teva Pharmaceuticals) and Professor Amanda Kirby (Do-IT Solutions) share how their experiences...

Medscape Education

- PMLiVE

Shionogi starts phase 2 clinical trial for Pompe Disease

The rare disease affects around one in every 22,000 people worldwide

- PMLiVE

Clasado appoints Sebastian Nummelin as new APAC Regional Director

Most recently Nummelin served as Director of APAC at TINE

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links